Growth Ahead For US Ophthalmic Surgery Systems Market
According to a recent Medtech Insight report, the US market for ophthalmic surgical systems totaled almost $1.7 billion in 2013, and is expected to experience healthy – if moderate – growth over the next five years, reaching an estimated $2.26 billion by 2018.
You may also be interested in...
South Korea has formulated new detailed policy measures to support the formation of major bioclusters, which will offer tax and other incentives in a bid to lure foreign firms and talent.
Abrysvo is recommended for use in pregnant people 32-36 weeks gestation if administered from September to January. For infants whose mothers were not vaccinated in this window, nirsevimab is recommended for prevention of respiratory syncytial virus infection.
Boehringer expects Jardiance’s new chronic kidney disease indication to keep its sales growing by double-digit percentages over the coming years, aided by the drug’s ability to reduce hospitalizations.